Sarepta Therapeutics Stock Price. Everything You Need To Know About The Sarepta Therapeutics Stock!
Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing treatments for rare diseases. The company focuses on RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities to help patients suffering from rare diseases. Its portfolio of therapeutic candidates includes treatments for Duchenne muscular dystrophy, Limb-girdle muscular dystrophies, and other neuromuscular and central nervous system disorders.
Sarepta Therapeutics, Inc. has a commercial presence with three FDA-approved products, including EXONDYS 51 (eteplirsen) Injection, VYONDYS 53 (golodirsen) Injection, and AMONDYS 45 (casimersen) Injection. These treatments are indicated for patients with Duchenne who have specific gene mutations. With more than 40 programs in its pipeline at various stages of discovery and clinical development, Sarepta Therapeutics, Inc. is actively working on developing treatments for patients with rare diseases.
Investors interested in the stock market can monitor the company’s share price, stocks share price today, and market cap to make informed investment decisions. Sarepta Therapeutics, Inc.’s focus on developing treatments for rare diseases positions it as an important player in the biopharmaceutical industry. As such, investors can benefit from keeping a close eye on the company’s performance, especially in the premarket.
Sarepta Therapeutics Stock Price. Everything You Need To Know About The Sarepta Therapeutics Stock! performance
- Employees 1162
- Company HQ Cambridge
- Website https://www.sarepta.com/
- SRPT Asset Type Common Stock
- SRPT Market Capitalization 12.2B
- Earnings Per Share -5.79
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Sarepta Therapeutics! As a renowned biotech company, Sarepta Therapeutics focuses on developing innovative RNA-based therapeutics to treat rare diseases. With a strong track record of bringing life-changing treatments to market, Sarepta offers immense potential for investors seeking promising investment opportunities. Investing in Sarepta Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam is now easier than ever with Zorion, the leading investment platform. Zorion offers a user-friendly interface that allows you to easily invest in real US stocks, including Sarepta Therapeutics, without the hassle of traditional brokerage accounts. Gain access to investment insights, personalized recommendations, and educational resources to make informed decisions about your investments. Start your investment journey today and seize the opportunity to be a part of Sarepta Therapeutics’ success story! Invest with Zorion and let your money work for you.
